ABSTRACT

Treatment modalities developed in intensive care units in recent years have led to the reduction of premature deaths from multiple organ failure (MOF). In patients with late period of MOF, the Chronic Critical Patient symptoms caused by the imbalance between Systemic Inflammatory Response syndrome and Compensatory Anti-inflammatory Response syndrome are observed frequently. Persistent Inflammation, Immunosuppression and Catabolism syndrome (PICS) have been defined in today’s intensive care practice as a catabolic patient group with recurrent episodes of infection with insuppressible inflammatory process. PICS should all be taken into consideration in the presence of persistent inflammation (C-reactive protein >150 μgr/dL), retinol binding protein <10 μgr/dL, lymphopenia (<800/mm3), catabolic status (albumin <3 g/dL, creatinine elevation index <80%, >10% weight loss or body mass index <18 occurred during intensive care unit stays) and inflammatory processes [interleukin (IL)-6, IL-10, IL-1ra, tumor necrosis factor receptor 1, procalcitonin] in more than 10 days of intensive care stay. It is aimed to avoid recurrent inflammation and to treat specific components of the syndrome by pharmacotherapy, physiotherapy and nutritional support. In this review, we aimed to recognize the phenomenon of PICS in daily intensive care practice, to understand the development mechanisms and to emphasize the importance of therapeutic research.

Keywords: Persistent, inflammation, immunosuppression, catabolism, PICS, multiple organ failure, Systemic Inflammatory Response syndrome, sepsis

References

Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 1995;75:257-77.

Faist E, Baue AE, Dittmer H, Heberer G. Multiple organ failure in polytrauma patients. J Trauma 1983;23:775-87.

Balogh Z, McKinley BA, Cox CS Jr, Allen SJ, Cocanour CS, Kozar RA, et al. Abdominal compartment syndrome: the cause or effect of postinjury multiple organ failure. Shock 2003;20:483-92.

Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996;24:163-72.

Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 2012;72:1491-501.

Mira JC, Brakenridge SC, Moldawer LL, Moore FA. Persistent Inflammation, Immunosuppression and Catabolism Syndrome. Crit Care Clin 2017;33:245-58.

Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, et al; BRAIN-ICU Study Investigators. Long-term cognitive impairment after critical illness. N Engl J Med 2013;369:1306-16.

Manz MG, Boettcher S. Emergency granulopoiesis. Nat Rev Immunol 2014;14:302-14.

Furze RC, Rankin SM. Neutrophil mobilization and clearance in the bone marrow. Immunology 2008;125:281-8.

Scumpia PO, Kelly-Scumpia KM, Delano MJ, Weinstein JS, Cuenca AG, Al-Quran S, et al. Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling. J Immunol 2010;184:2247-51.

Horiguchi H, Loftus TJ, Hawkins RB, Raymond SL, Stortz JA, Hollen MK, et al. Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy. Front Immunol 2018;9:595.

Prescott HC, Angus DC. Enhancing Recovery From Sepsis: A Review. JAMA 2018 2;319:62-75.